ArticleMedicine2020

Efficacy of weekly amrubicin for refractory or relapsed non-small cell lung cancer: A protocol of systematic review and meta-analysis.

Dong Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.